Others: GPC3 knockdown in ovarian cancer cells can lead to an increase in the expression of matrix metalloproteinase 2 (MMP-2) and MMP-9, along with a decrease in the level of tissue inhibitors of metalloproteinase 1 (TIMP-1) [103]. This evidence concerns the gene TIMP1 and ovarian cancer.